Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study (Q35907804)

From Wikidata
Jump to navigation Jump to search
scientific article published on 9 December 2011
edit
Language Label Description Also known as
English
Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study
scientific article published on 9 December 2011

    Statements

    Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study (English)
    Jasmin B Kuemmerle-Deschner
    Kieron S Leslie
    Richard Mouy
    Alberto Ferreira
    Karine Lheritier
    Neha Patel
    Ralph Preiss
    Philip N Hawkins
    Canakinumab in CAPS Study Group
    9 December 2011
    R202

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit